Fundamentals of Pediatric Drug Dosing (Record no. 4747)

MARC details
000 -LEADER
fixed length control field 02064nam a22002777a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240305192323.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220210b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783319437545
International Standard Book Number 3319437542
040 ## - CATALOGING SOURCE
Transcribing agency Data centre
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Iftekhar Mahmood
9 (RLIN) 30841
245 ## - TITLE STATEMENT
Title Fundamentals of Pediatric Drug Dosing
250 ## - EDITION STATEMENT
Edition statement illustrated
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Clinical Pharmacology/Biopharmaceutics Food & Drug Administration Silver Spring Maryland USA
Name of publisher, distributor, etc. Springer
Date of publication, distribution, etc. 2016
300 ## - PHYSICAL DESCRIPTION
Extent 146 pages
520 ## - SUMMARY, ETC.
Summary, etc. Focused on pediatric physiology, pharmacology, pharmacokinetics and pharmacodynamics, this book illustrates the differences between the pediatric population and adults; knowledge of extreme importance not only during pediatric drug development but also in the clinical practice. Physicians, nurses, clinical pharmacologists, researchers and healthcare professionals will find this an invaluable resource.<br/><br/>With the advent of pediatric exclusivity, and requirements to conduct clinical studies in children, an emphasis has been placed on finding a safe and efficacious dose of a drug in children. Children are not ‘small adults’, and drug dosing in this population requires special consideration. There are subtle physiological and biochemical differences among neonates, infants, children, adolescents and adults and dosing in pediatrics requires proper understanding of these factors. Furthermore, dosing in children, as in adults, should be based on pharmacokinetic and pharmacodynamic data. This is an evolving area, as pediatric pharmacokinetic studies are becoming mandatory for getting approval of new drugs in this population.
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Medical / Practice Management & Reimbursement
9 (RLIN) 26757
General subdivision Medical / Pharmacology
9 (RLIN) 27230
General subdivision Medical / Pediatrics
9 (RLIN) 26838
General subdivision Medical / Family & General Practice
9 (RLIN) 26950
General subdivision Medical / Clinical Medicine
9 (RLIN) 26816
General subdivision Medical › Pediatrics
9 (RLIN) 26964
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 30842
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type E-BOOKS
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Total checkouts Barcode Date last seen Price effective from Koha item type
            MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO   02/10/2022   EBS9220 02/10/2022 02/10/2022 E-BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024